Product Wiki · Recalls · EU Safety Gate (RAPEX)

Collier enfant ambre balte enfants enfants, couleur arc-en-ciel… — recall A12/03125/24

EU Safety Gate (RAPEX) · France · 2024-11-15 · Serious risk

As described by EU Safety Gate (RAPEX): Collier enfant ambre balte enfants enfants, couleur arc-en-ciel perles baroques noué

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/03125/24
Date of alert
2024-11-15
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Choking, Strangulation
Brand
Amber with love
Product category
Childcare articles and children's equipment
Product type
Teething necklace
Reported risk: The necklace does not open and can therefore wind around the neck of the child, leading to strangulation. Furthermore, the necklace can easily break, releasing small parts (the beads). A small child may put them in the mouth and choke.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Warning consumers of the risks
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Collier enfant ambre balte enfants enfants, couleur arc-en-ciel perles baroques noué

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10076446

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.